Biotechnology Company Legacy Infrastructure Protection Case Study

This case study details the partnership between a leading biotechnology company and ColorTokens to enhance the security of legacy systems. The biotechnology company, which focuses on neurological disease research and patient care, faced significant risks due to outdated systems that were no longer receiving security updates. The primary objective was to protect sensitive patient data and business information while complying with regulatory requirements. ColorTokens provided a Proof of Concept that demonstrated their ability to meet the company's desired outcomes, which included restricting connectivity to legacy systems, reducing the attack surface, and improving visibility and management of security policies. The implementation resulted in a significant reduction in unauthorized network connections and the attack surface, alongside a notable decrease in the blast radius of potential cyber threats. The successful deployment led to the biotechnology company expanding its security measures to include additional systems, showcasing the effectiveness of ColorTokens' solutions.